{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:31:37Z","timestamp":1788193897878,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SC1GM141937"],"award-info":[{"award-number":["SC1GM141937"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SB\/S2\/RJN-043\/2014"],"award-info":[{"award-number":["SB\/S2\/RJN-043\/2014"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.gene.2023.147612","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T21:09:59Z","timestamp":1688764199000},"page":"147612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity"],"prefix":"10.1016","volume":"881","author":[{"given":"Subhasish","family":"Maity","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0659-5469","authenticated-orcid":false,"given":"Ayantika","family":"Santra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda Vardhan","family":"Hebbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Pulakuntla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kameswara Rao","family":"Badri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaddi","family":"Damodara Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2023.147612_b0005","first-page":"167","article-title":"How the COVID-19 overcomes the battle? An approach to virus structure","volume":"14","author":"Ahmadpour","year":"2020","journal-title":"Iran. J. Kidney Dis."},{"key":"10.1016\/j.gene.2023.147612_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5582\/ddt.2020.03008","article-title":"Treatment of SARS-CoV-2: how far have we reached'","volume":"14","author":"Ahsan","year":"2020","journal-title":"Drug Discov. Ther."},{"issue":"4","key":"10.1016\/j.gene.2023.147612_b0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cbf.3182","article-title":"Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity","volume":"34","author":"Akpovwa","year":"2016","journal-title":"Cell Biochem. Funct."},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/jme.0.0280069","article-title":"Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids","volume":"28","author":"Almawi","year":"2002","journal-title":"J. Mol. Endocrinol."},{"issue":"39","key":"10.1016\/j.gene.2023.147612_b0025","doi-asserted-by":"crossref","first-page":"23379","DOI":"10.1039\/D0RA03774E","article-title":"Natural products' role against COVID-19","volume":"10","author":"Antonio","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.gene.2023.147612_b0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir Chem Chemother"},{"issue":"5","key":"10.1016\/j.gene.2023.147612_b0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2011-0392TR","article-title":"Role of chemokines in the pathogenesis of acute lung injury","volume":"46","author":"Bhatia","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.gene.2023.147612_b0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fphar.2019.00040","article-title":"CRP-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells","volume":"10","author":"Bian","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2023.147612_b0045","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3389\/fimmu.2020.01844","article-title":"Immunomodulatory Drugs in the Management of SARS-CoV-2","volume":"11","author":"Burrage","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.gene.2023.147612_b0055","doi-asserted-by":"crossref","first-page":"ofaa102","DOI":"10.1093\/ofid\/ofaa102","article-title":"High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019","volume":"7","author":"Cao","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.gene.2023.147612_b0060","first-page":"466","article-title":"Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease","volume":"7","author":"Capochiani","year":"2020","journal-title":"Analysis of Data Collection From RESPIRE Protocol. Frontiers in medicine"},{"key":"10.1016\/j.gene.2023.147612_b0065","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.4049\/jimmunol.167.5.2831","article-title":"Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2","volume":"167","author":"Caughey","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.gene.2023.147612_b0070","article-title":"Overview of lethal human coronaviruses","volume":"10;5(1):89","author":"Chen","year":"2020","journal-title":"Signal Transduct Target Ther."},{"issue":"4","key":"10.1016\/j.gene.2023.147612_b0075","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CMR.00023-07","article-title":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection","volume":"20","author":"Cheng","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0080","first-page":"333","article-title":"How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.gene.2023.147612_b0085","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"10.1016\/j.gene.2023.147612_b0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The Immunology of Macrophage Activation Syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.gene.2023.147612_b0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: The promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.gene.2023.147612_b0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rheumatology\/keh506","article-title":"Hydroxychloroquine therapy in patients with primary Sj\u00f6gren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase","volume":"44","author":"Dawson","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.gene.2023.147612_b0105","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.gene.2023.147612_b0110","doi-asserted-by":"crossref","unstructured":"Dhama, K., Patel, S. K., Sharun, K., Pathak, M., Tiwari, R., Yatoo., et al., 2020. SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel medicine and infectious disease,37,101830.","DOI":"10.1016\/j.tmaid.2020.101830"},{"issue":"3","key":"10.1016\/j.gene.2023.147612_b0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/157488706778250168","article-title":"Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases","volume":"1","author":"Ding","year":"2006","journal-title":"Rev. Recent Clin. Trials"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrrheum.2009.235","article-title":"Therapy: Hydroxychloroquine in SLE: old drug, new perspectives","volume":"6","author":"D\u00f6rner","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s42358-020-00134-8","article-title":"Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases","volume":"60","author":"Dos Reis Neto","year":"2020","journal-title":"Advances in rheumatology (London, England)"},{"key":"10.1016\/j.gene.2023.147612_b0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrg2323","article-title":"Rates of evolutionary change in viruses: patterns and determinants","volume":"9","author":"Duffy","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"6485","key":"10.1016\/j.gene.2023.147612_b0135","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.abb8034","article-title":"Misguided drug advice for COVID-19","volume":"367","author":"FitzGerald","year":"2020","journal-title":"Science (New York, N.Y.)"},{"issue":"6","key":"10.1016\/j.gene.2023.147612_b0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.gene.2023.147612_b0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.yexcr.2010.12.021","article-title":"Chemokines as targets for therapy","volume":"317","author":"Garin","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0150","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/annrheumdis-2020-217598","article-title":"Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)","volume":"80","author":"Giollo","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2023.147612_b0155","unstructured":"Gorenstein, S. A., Castellano, M. L., Slone, E. S., Gillette, B., Liu, H., Alsamarraie, C., et al., 2020. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 47(3), 405\u2013413."},{"issue":"12","key":"10.1016\/j.gene.2023.147612_b0160","doi-asserted-by":"crossref","first-page":"e0244628","DOI":"10.1371\/journal.pone.0244628","article-title":"Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis","volume":"15","author":"Gorham","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.gene.2023.147612_b0165","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jinf.2020.06.008","article-title":"Interleukin-6 as prognosticator in patients with COVID-19","volume":"81","author":"Grifoni","year":"2020","journal-title":"J. Infect."},{"issue":"4","key":"10.1016\/j.gene.2023.147612_b0170","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.gene.2023.147612_b0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13054-020-03215-8","article-title":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study","volume":"24","author":"Gucyetmez","year":"2020","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.gene.2023.147612_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00203-021-02606-x","article-title":"COVID-19: comprehensive review on mutations and current vaccines","volume":"204","author":"Hebbani","year":"2022","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.gene.2023.147612_b0195","doi-asserted-by":"crossref","unstructured":"Hermine, O., Mariette, X., Tharaux, P. L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, 2021. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. JAMA Internal Med., 181(1), 32\u201340.","DOI":"10.1001\/jamainternmed.2021.2209"},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.gene.2023.147612_b0205","doi-asserted-by":"crossref","unstructured":"Hu, D., Zhu, C., Ai, L., He, T., Wang, Y., Ye, F., et ., 2018. Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats. Emerging Microbes Infect.,7(1),154.","DOI":"10.1038\/s41426-018-0155-5"},{"issue":"10223","key":"10.1016\/j.gene.2023.147612_b0210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.gene.2023.147612_b0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000509483","article-title":"Weathering the Cytokine Storm in COVID-19: Therapeutic Implications","volume":"10","author":"Iannaccone","year":"2020","journal-title":"Cardiorenal medicine"},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/ars.2008.2140","article-title":"Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats","volume":"11","author":"Jain","year":"2009","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.gene.2023.147612_b0235","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting Interleukin-6 Signaling in Clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.gene.2023.147612_b0240","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.apsb.2020.04.009","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.gene.2023.147612_b0245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2011.04387.x","article-title":"Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy","volume":"164 Suppl 2(Suppl 2)","author":"Kaveri","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.gene.2023.147612_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110224","article-title":"Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?","volume":"144","author":"Kjellberg","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.gene.2023.147612_b0255","first-page":"23","article-title":"Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis","author":"Kumar","year":"2020","journal-title":"Diagnosis, and Therapeutics"},{"key":"10.1016\/j.gene.2023.147612_b0260","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/mr.56.1.61-79.1992","article-title":"RNA recombination in animal and plant viruses","volume":"56","author":"Lai","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.gene.2023.147612_b0265","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-017-0166-7","article-title":"Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention","volume":"14","author":"Lajoie","year":"2017","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.gene.2023.147612_b0270","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gene.2023.147612_b0275","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/jcm9082392","article-title":"Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis","volume":"9","author":"Lee","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0280","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.gene.2023.147612_b0285","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annual review of virology."},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0290","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","article-title":"Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia","volume":"9","author":"Lin","year":"2020","journal-title":"Emerging Microbes Infect."},{"key":"10.1016\/j.gene.2023.147612_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/v11110979","article-title":"Viral Metagenomics Revealed Sendai Virus and Coronavirus Infection of Malayan Pangolins (Manis javanica)","volume":"11","author":"Liu","year":"2019","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.gene.2023.147612_b0300","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","volume":"133","author":"Liu","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13287-020-01678-8","article-title":"Mesenchymal stem cells as a potential therapy for COVID-19","volume":"11","author":"Liu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.gene.2023.147612_b0310","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"'Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV","volume":"23","author":"Lu","year":"2015","journal-title":"MERS-CoV, and beyond', Trends Microbiol"},{"issue":"10224","key":"10.1016\/j.gene.2023.147612_b0315","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1213\/ANE.0000000000004845","article-title":"Coronaviruses and SARS-CoV-2: A Brief Overview","volume":"131","author":"Ludwig","year":"2020","journal-title":"Anesth Analg."},{"key":"10.1016\/j.gene.2023.147612_b0325","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.imlet.2020.09.007","article-title":"Cytokine storm, not only in COVID-19 patients","volume":"228","author":"Lukan","year":"2020","journal-title":"Mini-review. Immunology letters"},{"issue":"8","key":"10.1016\/j.gene.2023.147612_b0330","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.gene.2023.147612_b0335","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12985-015-0439-5","article-title":"MERS coronavirus: diagnostics, epidemiology and transmission","volume":"12","author":"Mackay","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.gene.2023.147612_b0340","article-title":"Covid-19: what treatments are being investigated?","volume":"368","author":"Mahase","year":"2020","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.gene.2023.147612_b0345","doi-asserted-by":"crossref","unstructured":"Mathuria, J. P., Yadav, R., Rajkumar., 2020. Laboratory diagnosis of SARS-CoV-2 - A review of current methods. Journal of infection and public health,13(7),901\u201390.","DOI":"10.1016\/j.jiph.2020.06.005"},{"issue":"12","key":"10.1016\/j.gene.2023.147612_b0350","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.intimp.2005.05.010","article-title":"Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family","volume":"5","author":"Mihara","year":"2005","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.gene.2023.147612_b0355","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.gene.2023.147612_b0360","doi-asserted-by":"crossref","first-page":"25359","DOI":"10.1038\/srep25359","article-title":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","volume":"6","author":"Min","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.gene.2023.147612_b0365","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.gene.2023.147612_b0370","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1177\/0961203315593169","article-title":"Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases","volume":"24","author":"Morel","year":"2015","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.gene.2023.147612_b0375","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/25785826.2020.1770948","article-title":"JAK inhibitors for the treatment of rheumatoid arthritis","volume":"43","author":"Morinobu","year":"2020","journal-title":"Immunological medicine"},{"key":"10.1016\/j.gene.2023.147612_b0380","doi-asserted-by":"crossref","unstructured":"Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao et al., 2020. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical care (London, England),24(1),422.","DOI":"10.1186\/s13054-020-03120-0"},{"issue":"18","key":"10.1016\/j.gene.2023.147612_b0385","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMp058068","article-title":"Preparing for the next pandemic","volume":"352","author":"Osterholm","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.gene.2023.147612_b0390","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3324\/haematol.2009.006965","article-title":"A role for the renin-angiotensin system in hematopoiesis","volume":"94","author":"Park","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0395","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40122-020-00173-5","article-title":"COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns","volume":"9","author":"Pergolizzi","year":"2020","journal-title":"Pain Ther."},{"key":"10.1016\/j.gene.2023.147612_b0400","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12916-023-02737-6","article-title":"Coding long COVID: characterizing a new disease through an ICD-10 lens","volume":"21","author":"Pfaff","year":"2023","journal-title":"BMC Med"},{"issue":"11","key":"10.1016\/j.gene.2023.147612_b0405","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1021\/acsomega.0c05996","article-title":"Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine. In Vitro Activity against SARS-CoV-2 and Potential Mechanisms","volume":"6","author":"Puhl","year":"2021","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.gene.2023.147612_b0410","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3947\/ic.2020.0126","article-title":"Ruxolitinib and the Mitigation of Severe COVID-19: A Systematic Review and Meta-analysis","volume":"53","author":"Quiros","year":"2021","journal-title":"Infection & chemotherapy"},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0415","first-page":"174","article-title":"SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview","volume":"28","author":"Rabaan","year":"2020","journal-title":"Infez. Med."},{"key":"10.1016\/j.gene.2023.147612_b0420","doi-asserted-by":"crossref","unstructured":"Radner, H., Aletaha, D. 2015. Anti-TNF in rheumatoid arthritis: an overview. Wiener medizinische Wochenschrift (1946),165(1-2),3\u20139.","DOI":"10.1007\/s10354-015-0344-y"},{"key":"10.1016\/j.gene.2023.147612_b0425","doi-asserted-by":"crossref","unstructured":"Raju, R., V, P., Biatris, P. S., J, S. J. U. C. 2021. Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials. Future journal of pharmaceutical sciences, 7(1), 67.","DOI":"10.1186\/s43094-021-00217-3"},{"issue":"7","key":"10.1016\/j.gene.2023.147612_b0430","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","article-title":"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \u201cstorm\u201d and risk factor for damage of hematopoietic stem cells","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2023.147612_b0435","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2172-6-2","article-title":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome","volume":"6","author":"Reghunathan","year":"2005","journal-title":"BMC Immunol."},{"key":"10.1016\/j.gene.2023.147612_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117839","article-title":"Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review","volume":"255","author":"Renu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.gene.2023.147612_b0445","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(20)30270-X","article-title":"Baricitinib for COVID-19: a suitable treatment? - Authors' reply","volume":"20","author":"Richardson","year":"2020","journal-title":"Lancet Infect Dis."},{"issue":"12","key":"10.1016\/j.gene.2023.147612_b0450","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2023.147612_b0455","doi-asserted-by":"crossref","unstructured":"Rieder, M., Duerschmied, D., Zahn, T., Lang, C., Benk, C., Lother, A., et al., 2021a. Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation. ASAIO journal (American Society for Artificial Internal Organs : 1992),67(3),332\u2013338.","DOI":"10.1097\/MAT.0000000000001302"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0460","doi-asserted-by":"crossref","first-page":"e043345","DOI":"10.1136\/bmjopen-2020-043345","article-title":"Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial","volume":"11","author":"Rieder","year":"2021","journal-title":"BMJ Open"},{"issue":"Pt 1)(Pt 1","key":"10.1016\/j.gene.2023.147612_b0465","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/bj3180325","article-title":"Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation","volume":"318","author":"Ristim\u00e4ki","year":"1996","journal-title":"Biochem. J."},{"issue":"21","key":"10.1016\/j.gene.2023.147612_b0470","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1111\/bph.15206","article-title":"Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19","volume":"177","author":"Robb","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.gene.2023.147612_b0475","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12950-021-00268-6","article-title":"Anti-inflammatory potential of Quercetin in COVID-19 treatment","volume":"18","author":"Saeedi-Boroujeni","year":"2021","journal-title":"Journal of inflammation (London, England)"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0485","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42358-020-0117-1","article-title":"Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant\/unresponsive familial Mediterranean fever","volume":"60","author":"\u015eahin","year":"2020","journal-title":"Advances in rheumatology (London, England)"},{"key":"10.1016\/j.gene.2023.147612_b0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphys.2017.00089","article-title":"Prostaglandin E2 As a Modulator of Viral Infections","volume":"8","author":"Sander","year":"2017","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.gene.2023.147612_b0495","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s42399-020-00363-4","article-title":"Comorbidity and its Impact on Patients with COVID-19","volume":"2","author":"Sanyaolu","year":"2020","journal-title":"SN comprehensive clinical medicine"},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0500","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","article-title":"COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?","volume":"38","author":"Sarzi-Puttini","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.gene.2023.147612_b0505","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1196\/annals.1408.002","article-title":"The molecular biology of SARS coronavirus","volume":"1102","author":"Satija","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0510","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Commun. Signal"},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0515","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.gene.2023.147612_b0520","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"'COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J Adv Res."},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0525","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"suppl_1","key":"10.1016\/j.gene.2023.147612_b0530","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","article-title":"Update on colchicine, 2017","volume":"57","author":"Slobodnick","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.gene.2023.147612_b0535","unstructured":"Sordillo, P. P., Helson, L. 2015. Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections. In vivo (Athens, Greece),29(1),1\u20134."},{"key":"10.1016\/j.gene.2023.147612_b0540","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"issue":"6","key":"10.1016\/j.gene.2023.147612_b0545","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"issue":"7","key":"10.1016\/j.gene.2023.147612_b0550","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-2600(21)00177-6","article-title":"Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial","volume":"9","author":"Supady","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.gene.2023.147612_b0555","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.gene.2023.147612_b0560","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S2213-2600(21)00222-8","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial","volume":"9","author":"Tardif","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"Suppl 1","key":"10.1016\/j.gene.2023.147612_b0565","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/rheumatology\/key225","article-title":"Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis","volume":"58","author":"Taylor","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.gene.2023.147612_b0570","doi-asserted-by":"crossref","unstructured":"Teijaro, J. R., Walsh, K. B., Rice, S., Rosen, H., Oldstone, M. B. 2014. Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proceedings of the National Academy of Sciences of the United States of America, 111(10), 3799\u20133804.","DOI":"10.1073\/pnas.1400593111"},{"issue":"3","key":"10.1016\/j.gene.2023.147612_b0575","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/biof.1633","article-title":"COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin","volume":"46","author":"Theoharides","year":"2020","journal-title":"BioFactors (Oxford, England)"},{"issue":"Sup5a","key":"10.1016\/j.gene.2023.147612_b0580","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/jowc.2020.29.Sup5a.S4","article-title":"Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series","volume":"29","author":"Thibodeaux","year":"2020","journal-title":"J. Wound Care"},{"issue":"5","key":"10.1016\/j.gene.2023.147612_b0585","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.gene.2023.147612_b0590","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0595","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"12","key":"10.1016\/j.gene.2023.147612_b0600","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1093\/cid\/ciaa1735","article-title":"The Misleading \u201cPooled Effect Estimate\u201d of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19)","volume":"72","author":"Tleyjeh","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.gene.2023.147612_b0605","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/ptr.6781","article-title":"Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19","volume":"34","author":"Tutunchi","year":"2020","journal-title":"Phytotherapy research : PTR"},{"key":"10.1016\/j.gene.2023.147612_b0610","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/135965350701200S01.1","article-title":"Human coronaviruses: what do they cause?","volume":"12","author":"van der Hoek","year":"2007","journal-title":"Antivir Ther."},{"issue":"3","key":"10.1016\/j.gene.2023.147612_b0615","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.16659","article-title":"Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients","volume":"189","author":"Wan","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.gene.2023.147612_b0620","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.18632\/aging.103000","article-title":"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2023.147612_b0625","author":"WHO"},{"issue":"8","key":"10.1016\/j.gene.2023.147612_b0630","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.gene.2023.147612_b0635","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clim.2007.08.013","article-title":"TNF-alpha blockade in human diseases: mechanisms and future directions","volume":"126","author":"Wong","year":"2008","journal-title":"Clinical immunology (Orlando, Fla.)"},{"key":"10.1016\/j.gene.2023.147612_b0640","first-page":"1260","volume":"367","author":"Wrapp","year":"2020","journal-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science"},{"issue":"13","key":"10.1016\/j.gene.2023.147612_b0645","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMc2016359","article-title":"Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2","volume":"383","author":"Wyllie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2023.147612_b0650","doi-asserted-by":"crossref","unstructured":"Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., et al., 2020. Effective treatment of severe COVID-19 patients with tocilizumab. Proceedings of the National Academy of Sciences of the United States of America, 117(20), 10970\u201310975.","DOI":"10.1073\/pnas.2005615117"},{"key":"10.1016\/j.gene.2023.147612_b0655","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gene.2023.147612_b0660","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jinf.2020.03.062","article-title":"The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis","volume":"81","author":"Yang","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.gene.2023.147612_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102434","article-title":"The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China","volume":"109","author":"Yang","year":"2020","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.gene.2023.147612_b0670","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10072-016-2576-z","article-title":"Elevated serum IL-11, TNF \u03b1, and VEGF expressions contribute to the pathophysiology of hypertensive intracerebral hemorrhage (HICH)","volume":"37","author":"Yang","year":"2016","journal-title":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"6","key":"10.1016\/j.gene.2023.147612_b0675","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"issue":"10","key":"10.1016\/j.gene.2023.147612_b0680","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.7150\/ijbs.45472","article-title":"Zoonotic origins of human coronaviruses","volume":"16","author":"Ye","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.gene.2023.147612_b0685","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/v12060582","article-title":"Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2","volume":"12","author":"Younes","year":"2020","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.gene.2023.147612_b0690","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.gene.2023.147612_b0695","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood-2008-03-144766","article-title":"Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells","volume":"112","author":"Zambidis","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.gene.2023.147612_b0700","doi-asserted-by":"crossref","unstructured":"Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., et al., 2020. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clinical immunology (Orlando, Fla.), 214, 108393.","DOI":"10.1016\/j.clim.2020.108393"},{"issue":"6","key":"10.1016\/j.gene.2023.147612_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105982","article-title":"Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies","volume":"55","author":"Zhao","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7700","key":"10.1016\/j.gene.2023.147612_b0710","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41586-018-0010-9","article-title":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin","volume":"556","author":"Zhou","year":"2018","journal-title":"Nature"},{"issue":"7798","key":"10.1016\/j.gene.2023.147612_b0715","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111923004535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111923004535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T17:05:13Z","timestamp":1759856713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111923004535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":143,"alternative-id":["S0378111923004535"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2023.147612","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2023.147612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"147612"}}